Startseite>>Signaling Pathways>> PROTAC>> E3 Ligase Ligand-Linker Conjugate>>Lenalidomide-C5-NH2 TFA

Lenalidomide-C5-NH2 TFA

Katalog-Nr.GC64104

Lenalidomid-C5-NH2 ist der Lenalidomid-basierte Cereblon-Ligand, der zur Rekrutierung des CRBN-Proteins verwendet wird. Lenalidomid-C5-NH2 kann mit dem Liganden fÜr Protein durch einen Linker verbunden werden, um PROTACs zu bilden, wie z. B. MDM2 PROTAC-Abbaumittel.

Products are for research use only. Not for human use. We do not sell to patients.

Lenalidomide-C5-NH2 TFA Chemische Struktur

Größe Preis Lagerbestand Menge
100 mg
360,00 $
Auf Lager
500 mg
855,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Lenalidomide-C5-NH2 is the Lenalidomide-based Cereblon ligand used in the recruitment of CRBN protein. Lenalidomide-C5-NH2 can be connected to the ligand for protein by a linker to form PROTACs, such as MDM2 PROTAC degrader[1][2].

[1]. Zhou B, et al. Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression. J Med Chem. 2018;61(2):462-481.
[2]. Li Y, Yang J, et al. Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression. J Med Chem. 2019;62(2):448-466.

Bewertungen

Review for Lenalidomide-C5-NH2 TFA

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Lenalidomide-C5-NH2 TFA

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.